| | | | | China's health regulator has ordered local medical institutions to stop using a heart drug from Zhejiang Huahai Pharmaceutical Co Ltd, in a directive that comes just days after another case of a tainted medical product. | | |
| | | Indivior said on Monday a U.S. Court expedited a generic rival's appeal against a preliminary injunction that blocked the sale of a copycat version of the British drugmaker's blockbuster opioid addiction treatment. | | |
| | | (Reuters Health) - The vaccine Shingrix prevents shingles, and if people do contract the virus, it reduces the severity of illness, two company-funded study suggests. | | |
| | | (Reuters Health) - Adolescents may be cautious while they're learning to drive, but a new study suggests they get downright dangerous once their license allows them to hit the road without a grownup in the car. | | |
| | | Insys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller, citing potential safety concerns. | | |
| | | Bayer AG disputed accusations in a new Netflix documentary that claims medical device makers and the U.S. Food and Drug Administration placed profits before patient safety. | | |
| | | (Reuters Health) - Shots from high caliber firearms are more likely to kill, a new study suggests. | | |
| | | (Reuters Health) - Patients don't see a difference in competence, professionalism or trustworthiness when doctors sport tattoos or piercings, a small U.S. study suggests. | | |
| | | GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday. | | |
| | | GlaxoSmithKline drug Nucala has won a key recommendation from a European Medicines Agency (EMA) panel for use in the treatment of children with severe asthma, the company said in a statement on Friday. | | |
| | | Bayer won the European Medicines Agency's (EMA) recommendation for widening the use of its blockbuster clot prevention drug Xarelto to include atherosclerosis patients, opening a potentially lucrative new market. | | |
|
| |
